Literature DB >> 24618569

Aniridic Glaucoma: Long-term Visual Outcomes and Phenotypic Associations.

Amit Jain1, Shikha Gupta, Mathew K James, Paromita Dutta, Viney Gupta.   

Abstract

PURPOSE: The aim of this study was to evaluate long-term visual outcomes in patients with aniridic glaucoma.
DESIGN: Retrospective noncomparative observational case series.
MATERIALS AND METHODS: A review of medical records of 128 eyes of 64 consecutive patients with aniridic glaucoma, diagnosed after the age of 5 years was analyzed. The parameters studied included age at presentation, family history, baseline intraocular pressure (IOP), type and the number of surgical interventions, and associated comorbidities. PRIMARY OUTCOME MEASURE: Best corrected visual acuity (BCVA) in the better eye.
RESULTS: Mean age at presentation was 15.86±10.11 years (range, 5 to 47 y). The average follow-up was 7.69±4.98 years (range, 1 to 17 y). At the final follow up only 18 patients had BCVA better than 6\60 and only 5 patients had BCVA of >6/18. Seventeen of the 64 (26.5%) patients developed phthisis in 1 eye. The final visual outcomes were not associated with age at presentation (P=0.64) or sex (P=0.76); however, those with a higher baseline IOP (P=0.017), those with familial aniridia (P=0.037), and those who underwent more number of surgical interventions had poorer visual outcomes (P=0.004). Kaplan-Meier analysis demonstrated the probability of bilateral blindness to be 69.8% and 97.6% at 5 and 10 years, respectively.
CONCLUSIONS: Long-term visual outcomes after therapy among aniridic glaucoma patients remain poor. Higher baseline IOP, the presence of familial aniridia, and a history of greater number of surgical interventions are associated with poorer long-term visual outcomes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24618569     DOI: 10.1097/IJG.0000000000000019

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  7 in total

1.  Clinical outcomes and visual prognostic factors in congenital aniridia.

Authors:  Adam Jacobson; Shahzad I Mian; Brenda L Bohnsack
Journal:  BMC Ophthalmol       Date:  2022-05-25       Impact factor: 2.086

2.  Congenital aniridia: etiology, manifestations and management.

Authors:  Monica Samant; Bharesh K Chauhan; Kira L Lathrop; Ken K Nischal
Journal:  Expert Rev Ophthalmol       Date:  2016-03-09

3.  Improving long-term intraocular pressure and visual outcomes in eyes with aniridic glaucoma.

Authors:  Ramanjit Sihota; Harathy Selvan; Kishan Azmira; Tanuj Dada; Ajay Sharma; Amisha Gupta; Ashish Upadhyay
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-07-30       Impact factor: 3.117

Review 4.  Short- and Long-term Results of Glaucoma Valve Implantation for Aniridia-related Glaucoma: A Case Series and Literature Review

Authors:  Gülizar Soyugelen Demirok; Ümit Ekşioğlu; Mehmet Yakın; Ahmet Kaderli; Sema Tamer Kaderli; Firdevs Örnek
Journal:  Turk J Ophthalmol       Date:  2019-09-03

5.  Use of the XEN gel implant in a patient with aniridia-associated glaucoma.

Authors:  Are Lindland; John-Thomas Edward Michelet; Jon Erik Slagsvold
Journal:  Am J Ophthalmol Case Rep       Date:  2021-03-31

6.  Congenital aniridia: clinical profile of children seen at the University College Hospital, Ibadan, South-West Nigeria.

Authors:  Mary Ogbenyi Ugalahi; Folahan Adesola Ibukun; Bolutife Ayokunnu Olusanya; Aderonke Mojisola Baiyeroju
Journal:  Ther Adv Ophthalmol       Date:  2021-05-31

Review 7.  Clinical and molecular aspects of congenital aniridia - A review of current concepts.

Authors:  Shailja Tibrewal; Ria Ratna; Abha Gour; Sumita Agarkar; Suneeta Dubey; Suma Ganesh; Ramesh Kekunnaya; Virender Sangwan; Yutao Liu; Vanita Vanita
Journal:  Indian J Ophthalmol       Date:  2022-07       Impact factor: 2.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.